Pursuant to Regulation 30(6) of the SEBI (Listing Obligations & Disclosure Requirements), Regulations, 2015, Neuland Laboratories has informed about the details of the Analyst/Institutional Investor meetings.
The above information is a part of company’s filings submitted to BSE.